Antoni Ribas
InvestorVenture Partner at Ysios Capital
Find your path to Antoni
32 people in our graph share verified history with Antoni — schools, employers, funds. One of them is your warm intro.
About
Antoni Ribas, M.D., Ph.D., is a physician-scientist and Professor of Medicine, Surgery, and Molecular and Medical Pharmacology at UCLA, where he directs the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center and the Parker Institute for Cancer Immunotherapy Center. His research focuses on malignant melanoma, gene-engineered T cells, PD-1 blockade, and BRAF-targeted therapies, and he contributed to the clinical development of several FDA-approved drugs including pembrolizumab, vemurafenib, and dabrafenib. He currently serves as President of the American Association for Cancer Research and is an elected member of the U.S. National Academy of Medicine.
Invests in
Biotech
Colleagues at Ysios Capital
Frequently asked questions
- Who is Antoni Ribas?
- Antoni Ribas, M.D., Ph.D., is a physician-scientist and Professor of Medicine, Surgery, and Molecular and Medical Pharmacology at UCLA, where he directs the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center and the Parker Institute for Cancer Immunotherapy Center. His research focuses on malignant melanoma, gene-engineered T cells, PD-1 blockade, and BRAF-targeted therapies, and he contributed to the clinical development of several FDA-approved drugs including pembrolizumab, vemurafenib, and dabrafenib. He currently serves as President of the American Association for Cancer Research and is an elected member of the U.S. National Academy of Medicine.
- Where does Antoni Ribas work?
- Antoni Ribas is Venture Partner at Ysios Capital.
- What does Antoni Ribas invest in?
- Antoni Ribas invests in Biotech.